Evidence map›Paper›PMID 40079104›Full record

ArticleHaematologica2025

Hemophilia is associated with accelerated biological aging.

Marina Trappl, Rafaela Vostatek, Manuel Salzmann, Daniel Kraemmer, Johanna Gebhart, Philipp Hohensinner, Ingrid Pabinger, Cihan Ay

Abstract read
In one paragraph

Article in Haematologica, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Observational
  2. Article
  3. The Epigenetic Landscape of Hemophilia.Current molecular medicine · 2026
    Review
  4. Article
  5. Spinal Stenosis: An Emerging Complication of Ageing in People With Haemophilia.Haemophilia : the official journal of the World Federation of Hemophilia · 2025
    Article
  6. Review
  7. Epigenetic Aging Signatures in People with Hemophilia.TH open : companion journal to thrombosis and haemostasis · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Marina TrapplDivision of Haematology and Haemostaseology, Department of Medicine I, Medical University of Vienna; Vienna.
Rafaela VostatekDivision of Haematology and Haemostaseology, Department of Medicine I, Medical University of Vienna; Vienna.
Manuel SalzmannLudwig Boltzmann Institute for Cardiovascular Research, Medical University of Vienna, Vienna, Austria; Department of Internal Medicine II, Division of Cardiology, Medical University of Vienna, Vienna.
Daniel KraemmerDivision of Haematology and Haemostaseology, Department of Medicine I, Medical University of Vienna; Vienna.
Johanna GebhartDivision of Haematology and Haemostaseology, Department of Medicine I, Medical University of Vienna; Vienna.
Philipp HohensinnerLudwig Boltzmann Institute for Cardiovascular Research, Medical University of Vienna, Vienna, Austria; Center for Biomedical Research, Medical University of Vienna, Vienna.
Ingrid PabingerDivision of Haematology and Haemostaseology, Department of Medicine I, Medical University of Vienna; Vienna.
Cihan AyDivision of Haematology and Haemostaseology, Department of Medicine I, Medical University of Vienna; Vienna. cihan.ay@meduniwien.ac.at.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hemophilia is a rare X-linked bleeding disorder caused by mutations in the F8 or F9 gene (hemophilia A or B), leading to deficient factor VIII or IX proteins, respectively. Hemophilia-related complications caused by bleeding into the joints (the hallmark of hemophilia) and age-related comorbidities occur frequently and impact the functionality and quality of life of persons with hemophilia (PwH). Given the chronic nature of hemophilia, we hypothesized that hemophilia has an association with accelerated biological aging. Therefore, we investigated biological aging biomarkers, i.e., telomere length and mitochondrial DNA (mtDNA) copy number with a quantitative polymerase chain reaction-based assay in PwH (N=99) and age- and sex-matched healthy controls (N=61). The association of telomere length and mtDNA copy number with hemophilia severity was investigated using ordinary least-squares linear regression models allowing for interactions with chronological age. Telomere length (6.09 [interquartile range (IQR), 4.79-7.68] kb vs. 10.07 [IQR, 7.93-12.66] kb; P<0.001) and mtDNA copy number (243.17 [IQR, 206.54-293.79] vs. 495.52 [IQR, 399.60-615.06]; P<0.001) were significantly lower in PwH compared to healthy controls. Persons with severe hemophilia had longer telomere length than those with non-severe hemophilia (6.29 [IQR, 5.36-8.05] kb vs. 5.12 [IQR, 3.97-6.58] kb), while no difference in mtDNA copy number was observed. We observed accelerated biological aging, indicated by shorter telomere length and lower mtDNA copy number, in PwH compared to healthy controls. Interestingly, telomere length shortening was more pronounced in non-severe than in severe hemophilia, which needs further investigations. Further research is needed to understand the underlying mechanisms of biological aging in hemophilia.

Indexed as

AgingHemophilia AAdolescentAdultAgedBiomarkersCase-Control StudiesDNA Copy Number VariationsDNA, MitochondrialFemaleHumansMaleMiddle AgedTelomereYoung AdultBiomarkersDNA, Mitochondrial

Identifiers

PMID40079104
PMCPMC12399931

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.